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Abstract
Background: Risk factors for influenza hospitalization in Africa are unknown, including the role of HIV.
Methods: We conducted a case-control study of risk factors for hospitalized seasonal influenza among persons in rural
western Kenya, a high HIV prevalence area, from March 2006- August 2008. Eligible cases were $five years old, admitted to
health facilities with respiratory symptoms, and had nasopharyngeal/oropharyngeal swab specimens that tested positive for
influenza A or B by real-time reverse transcription-PCR. Three randomly selected age-, sex- and neighborhood-matched
controls were enrolled per case. A structured questionnaire was administered and home-based HIV testing was performed.
Risk factors were evaluated using conditional logistic regression.
Results: A total of 64 cases (38 with influenza A and 26 with influenza B) and 190 controls were enrolled. The median age
was 16 years (range 5–69 years). Among cases, 24.5% were HIV-infected versus 12.5% of controls (p=0.004). Among persons
$18 years old, 13 (59%) of 22 tested cases were HIV-positive compared with 15 (24%) of 62 tested controls (p=0.005). In
multivariable analysis, HIV-infection was associated with hospitalization due to influenza [adjusted Odds Ratio (aOR) 3.56,
95% CI 1.25–10.1]. The mean CD4 count among HIV-infected cases and controls was similar (399 vs. 387, respectively,
p=0.89). Chronic lung disease (aOR 6.83, 95% CI 1.37–34.0) was also associated with influenza hospitalization in
multivariable analysis. Active pulmonary tuberculosis was associated with influenza hospitalization in bivariate, but not
multivariable, analysis.
Conclusions: People with HIV infection and chronic lung disease were at increased risk of hospitalized influenza in rural
Kenya. HIV infection is common in many parts of sub-Saharan Africa. Influenza vaccine might prevent severe influenza in
these risk groups.
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Introduction
Despite the worldwide impact of influenza, to date most
epidemiologic data on the burden of influenza have come from
developed countries, with little data from sub-Saharan Africa
[1,2]. Only one study from South African children has calculated
an incidence of severe seasonal influenza infection and little is
known about the seasonality of influenza in Africa, outside of
South Africa and Madagascar [2,3]. Moreover, there is little
diagnostic testing for influenza in clinical settings and rare
availability of influenza vaccine, entirely in the private market,
in most of Africa [2,4]. Lastly, little is known about the risk factors
for influenza infection in Africa [2].
There are several factors in Africa that might lead to unique
epidemiologic characteristics and a different clinical spectrum of
influenza disease. Comorbid infections, such as HIV, tuberculosis
and malnutrition, are highly prevalent in Africa [2,3,5,6]. In many
parts of Africa, like western Kenya, over 15% of adults are HIV-
infected and a third of children are malnourished (KEMRI/CDC
unpublished data) [7,8]. In addition, social mixing patterns are
different than in developing countries, with more crowding within
households and public places, like markets, which can lead to more
opportunities for person-to-person transmission of influenza virus.
As such, it is relevant to define distinct risk factors in the African
setting for use in targeting prevention measures [2].
To better characterize the disease burden and epidemiology of
seasonal influenza in Africa, population-based surveillance for
hospitalized influenza was implemented in inpatient health
facilities in Bondo District in rural western Kenya in 2006–2008.
We conducted a retrospective, matched case-control study to
identify risk factors, including HIV infection, for hospitalized
influenza among persons $five years old.
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Ethical review
This study was approved by the institutional review boards of
US Centers for Disease Control and Prevention (CDC) and Kenya
Medical Research Institute (KEMRI). Written informed consent
was obtained for all participants for questionnaires and HIV-
testing, and for linking the two databases. For children aged 5–6
years old, parental consent was obtained. For persons aged 7–17
years old, parental consent and individual assent was obtained.
Setting
Bondo District, part of Nyanza Province, in rural, western
Kenya, with approximately 238,078 residents in 1999, is
predominantly of Luo ethnicity [9]. Fishing and subsistence
farming are the main economic activities. Those rearing domestic
animals commonly go to crowded animal markets to buy or sell
animals. HIV prevalence in Nyanza Province is the highest in
Kenya, 15.3% among 15–49 year olds in 2007 compared to the
national average of 7.4%. [8]. The district, one of the poorest in
Kenya, is holoendemic for malaria, and has a high child mortality
rate [9]. Bondo District has seven (four public and three private)
inpatient facilities, including one government-operated district
hospital, and 45 outpatient facilities. Influenza vaccination was not
available in Bondo during the study period.
CDC’s Global Disease Detection Division, along with KEMRI,
established surveillance for influenza in all seven inpatient facilities
in Bondo District by May 2007. The Bondo surveillance was
initiated as a population-based surveillance site to complement
sentinel influenza surveillance undertaken by the Kenya Ministry
of Health in several provincial hospitals in Kenya to better
characterize seasonal and epidemic influenza. For this study,
screening criteria followed a suggested definition of severe acute
respiratory illness proposed for influenza surveillance in develop-
ing countries, defined as a hospitalized patient $five years old with
cough, shortness of breath, difficulty in breathing, or pleuritic
chest pain and either oxygen saturation of ,90% or axillary
temperature $38uC [10]. Of note, surveillance nurses examined
patients after they were admitted; the admitting clinicians did not
apply or use the same case definition in their decision to admit
patients.
Laboratory
Nasopharyngeal and oropharyngeal swabs were collected by
nurses and placed together into one cryotube containing one mL
virus transport media without antibiotics. Specimens from three
hospitals were kept in a cool box with ice packs at 2–8uC that was
transported daily to the KEMRI/CDC laboratory and then stored
at 270uC until testing. In four facilities where daily transportation
was not possible, specimens were stored immediately in liquid
nitrogen for up to 2 weeks. The frozen specimens from all sites
were transported to the testing laboratory on dry ice. Testing for
influenza viruses was carried out after one freeze-thaw cycle using
real-time reverse transcription-polymerase chain reaction (rRT-
PCR). Samples were aliquoted and total RNA was extracted from
100 mL aliquots of each sample using Qiagen’s QIAamp viral
RNA minikit (Qiagen inc, Valencia CA, USA), according to the
manufacturer’s instructions. One step rRT-PCR was carried out
using the AgPath kit (Applied Biosystems, California USA) and
results obtained following procedures provided by the Centers for
Disease Control and Prevention , USA (Lindstrom, personal
communication). This protocol is available under a material
transfer agreement from CDC upon request. Cycle threshold (CT)
values #39.9 were considered positive. All results were reviewed
by the laboratory supervisor before being considered final.
The standard Kenya Ministry of Health HIV testing algorithm
was administered, using parallel rapid test kits using whole blood
obtained from finger-prick -Determine HIV-1/2 (Abbott Diag-
nostic Division, Hoofdorp, Netherlands) and BiolineH(Standard
Diagnostics Inc, Korea)-with tie-breaking of discordant results
using Unigold
TM (Trinitiy Biotech PLC, Ireland). Blood specimens
for CD4 cell count were collected in EDTA-containing vacutainer
tubes and transported at 20–25uC to the CDC HIV reference
laboratory within 12 hours of collection. CD4 cell count was
processed using a BD FACSCount
TM machine (Becton-Dickinson,
Maryland).
Case-control study
We conducted an age-, sex- and neighborhood-matched case
control study. Eligible cases were hospitalized persons who met
screening criteria and had influenza A or B detected by rRT-PCR
between 26
th March 2006 and 28
th August 2008. Case enrollment
took place in their homes, several weeks to months after their
hospitalization, due to delays between collection and testing of
specimens. Three attempts were made to locate eligible cases.
Three controls were sought for each case. Controls were matched
using the following age strata; 5–9, 10–14, 15–19, 20–29, 30–39,
40–49, 50–59, 60–69 and $70 years. Persons who had a
respiratory illness requiring hospitalization during the last one
year were excluded as controls to prevent misclassification bias.
To identify the first eligible person to serve as a control, we spun
a bottle at the gate of the case’s house and then walked in the
direction the bottle pointed. After passing the first homestead in
that direction, we approached the second homestead, where we
looked for an age-eligible person to serve as a control, including
those not at home. If at home, we offered enrollment to the age-
eligible person. If more than one age-eligible person lived in the
household, we assigned them numbers. A number was randomly
selected and that person was offered enrollment. If the identified
age-eligible person was not home, at least three return visits were
made to enroll them. If no controls were able to be enrolled in the
identified homestead, we continued walking in the same direction
until we found a homestead with an eligible person who agreed to
be enrolled as a control. The second and third controls were
selected in the next two homesteads in the same direction as the
original bottle spin using the same methodology. A desired sample
size of 53 cases and 159 controls was calculated using the
expectation that 35% of cases would have HIV, the main risk
factor of interest, compared with 15% of controls (the HIV
prevalence among adults in Nyanza Province), using a power of
80% and a type I error rate of 5% [8].
A standardized, closed-ended questionnaire was administered to
cases and controls by trained field workers. Cases were asked
about exposures during the seven-day period prior to illness onset.
Controls were asked about exposures during the same seven-day
period as their matched case. Since interviews occurred up to
three months after the time period in question, in order to aid
people’s memories during interviews, we mentioned notable local
or national events that occurred during the reference period. Next
of kin were interviewed for case-patients that had died. The risk
factors assessed among both cases and controls included exposure
to indoor smoke, smoking cigarettes, drinking alcohol, exposure to
children, and presence of chronic medical conditions. The chronic
medical conditions assessed included asthma, chronic heart and
lung disease, diabetes and current pulmonary tuberculosis, all of
which were identified by self-report and verified by a clinician’s
diagnosis or relevant medications that a clinician had prescribed,
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and prescription notes that the participant kept in the home.
Chronic lung disease was defined as a history of prolonged or
recurrent cough or chest pain lasting more than two weeks in a
person without known asthma or pulmonary tuberculosis. We also
asked about domestic animal ownership (i.e. cows, sheep, donkeys,
and chickens) and number of animals owned.). Data on level of
education (none, primary, secondary, post-secondary), household
possessions (radio, sofa, lantern, TV, bicycle), and main source of
income for the household head and spouse were also collected and
used as proxy measures of socioeconomic status. Scannable paper
forms were used (TeleFormH software , Cardiff
TM, Vista, CA).
Inconsistent or illogical data were returned to the field for
correction.
Home-based HIV testing was attempted on all cases and
controls by a separate team of trained counselors. HIV-testing was
done as described above.
Analysis
Data were analyzed using EPI-INFO (version 3.4.1, Atlanta,
GA) and SAS (version 9.2, Cary, NC). Bivariate analysis was
performed, accounting for matching, producing a matched odds
ratio with 95% confidence intervals using the Mantel-Haenzel
method. P values were calculated for categorical variables using
Mantel-Haenzel chi- square test or Fisher’s exact test as
appropriate, and the Wilcoxon rank sum test was used to compare
continuous variables. Variables that had a p value ,0.10 were
included in conditional logistic regression. Using stepwise
backward elimination, variables were removed until only variables
with a p value ,0.05 were retained. Interaction was assessed by
inclusion of product terms for all variables remaining in the final
model. Population attributable risk percent was calculated using
the formula for case-control studies proposed by Bruzzi et al [11].
Results
A total of 64 cases and 190 controls were enrolled. For two
cases, only two matching controls could be found. Among cases,
38 (59.4%) were infected with influenza A virus and 26 (40.6%)
with influenza B virus. The median age was 16 years (range 5–69
years); there was no statistically significant age difference between
influenza A and influenza B patients (median 19.5 versus 14.5
years, p=0.22). The subtypes for seasonal influenza A viruses
from 17 cases in which sub-typing was done were H3N2 (ten cases)
and H1N1 (seven cases).
The demographic characteristics of cases and controls were
similar (table 1). A total of 53 (82.8%) cases and 136 (71.6%)
controls were tested for HIV among the 57 cases and 173
controls approached for HIV testing. Participants were not tested
for HIV either because they refused testing (n=22) or migrated
out of the area (n=17) or had died (n=2). There was no
significant difference in age or sex of those tested compared with
those not tested for HIV. Thirteen (24.5%) cases and 17 (12.5%)
controls tested positive for HIV (p=0.004). Among persons $18
years old, 13 (59%) of 22 tested cases were HIV-positive
compared with 15 (24%) of 62 tested controls (p=0.005). HIV-
positive cases and controls did not differ in CD4 count or
treatment status (Table 2). The principal admitting diagnoses
given by the admitting clinicians among cases were malaria
(29.0%), pneumonia (27.4%) and diarrheal illness (4.8%); there
were no differences in admitting diagnosis between HIV-positive
and HIV-negative patients. The median number of days of
hospitalization was two days (range zero to six); there was no
significant difference in the median length of stay for HIV-
positive and HIV-negative patients (2.0 vs. 1.5 days, p=0.45). No
case-patients died in hospital, but two (3.1%) died between
hospital discharge and enrollment.
Table 1. Description of the study participants in case-control study of risk factors for hospitalized influenza, Bondo District, Kenya,
2007-9.
Factor Cases, N=64 Controls, N=190 P value
Median age years (range) 16 (15–67) 16 (5–69) 0.70
Age in years-n (%)
5–9 16 (25.0) 54 (28.4) 0.37
10–17 18 (28.1) 48 (25.3)
18–34 12 (18.8) 51 (26.8)
35–49 13 (20.3) 22 (11.6)
$50 5 (7.8) 15 (7.9)
Male–n (%) 30 (46.9) 89 (46.8) 1.0
Education–n (%)
None 9 (14.1) 30 (15.8) 0.91
Primary 50 (78.1) 142 (74.7)
Secondary and above 5 (7.9) 18 (9.5)
Mean household size (SD) 5.9 (2.5) 5.6 (2.5) 0.50
Household with children,5 years–n (%) 43 (67.2) 120 (63.2) 0.54
Keep domestic animals–n (%) 64 (100) 182 (95.8) 0.09
Use firewood for cooking–n (%) 57 (89.1) 170 (89.5) 0.93
Cooking inside the house–n (%) 35 (59.3) 86 (55.1) 0.58
Smokes cigarettes–n (%) 3 (4.7) 7 (3.7) 0.72
Drinks alcohol–n (%) 3 (4.7) 15 (7.9) 0.29
doi:10.1371/journal.pone.0020111.t001
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including chronic lung disease, current pulmonary tuberculosis
and HIV infection, were associated with influenza A and B
hospitalization (Tables 3, 4, 5). Ownership of cattle and chickens
were also associated with influenza hospitalization. Exposure to
indoor smoke, smoking cigarettes, educational status, source of
income and socioeconomic status, as determined by household
possessions, were not associated with influenza hospitalization.
Although those who had co-infection of HIV and pulmonary
tuberculosis (n=3) were at high risk of hospitalized influenza, this
association did not achieve statistical significance (ORMH 6.00,
95% CI 0.54-66.17).
In multivariable analysis of influenza hospitalization (either A or
B), chronic lung disease, which excluded active pulmonary TB and
asthma, had the strongest association with influenza hospitaliza-
tion (aOR 6.83, 95% CI 1.37–34), although only 6 (9.4%) cases
had chronic lung disease, yielding a population attributable risk
percent of 8% (Table 3). HIV-infected persons were 3.56 times
more likely to be hospitalized with influenza (95% CI 1.25–10.07).
The population attributable risk percent of HIV infection was
15%. Patients with influenza hospitalization were two times more
likely to own cattle than controls (aOR 2.02, 95% CI 1.01-4.07).
Also, the risk of influenza hospitalization increased by 4% (95% CI
1–7%) with each additional chicken owned.
We assessed variables associated with influenza A hospitaliza-
tion separately (Table 4). In multivariable analysis, HIV infection
had the strongest association (aOR 3.87, 95% CI 1.13 – 13.23.)
Hospitalized influenza A patients also had a higher median
number of chickens than controls (aOR 1.05, 95% CI 1.01–1.08).
Influenza B hospitalization was associated with chronic lung
disease and cattle ownership in bivariate analysis. Chronic lung
disease remained strongly associated with hospitalized influenza in
the multivariable model (aOR 7.11, 95% CI 1.38–36.75, Table 5).
Although HIV-infection was not statistically significantly associat-
ed with laboratory-confirmed influenza B hospitalization, it was
more common among cases (aOR 3.26, 95% CI 0.43–39.7).
Discussion
This is the first study to describe risk factors for seasonal
influenza hospitalization among older children and adults in Africa
[2]. Our findings suggest that persons with chronic underlying
illnesses, particularly HIV and chronic lung disease, are at
increased risk of influenza-associated hospitalization, and would
be priority candidates for influenza vaccination. While these
factors are not unique to Africa, they are more common in Africa
and therefore may play a larger role in the epidemiology of severe
influenza.
Few studies have investigated the risk of influenza hospitaliza-
tions in HIV-infected persons [2]. In South Africa, HIV-infected
children with confirmed influenza had an estimated eight-fold
increased risk of hospitalization than did HIV-negative children
Table 2. Selected treatment characteristics of HIV-positive participants in case-control study of risk factors for hospitalized
influenza, Bondo District, Kenya, 2007-9.
Characteristic Cases N=13 n (%) Controls N=17 n (%) P value
On antiretroviral therapy 3 (23.1) 3 (17.6) 0.53
On Septrin prophylaxis 2 (15.4%) 4 (23.5%) 0.47
CD4 cell count (mean6SD)
a 399 (184) 387 (234) 0.89
CD4 count
a
,250 1 (10.0%) 5 (33.3%) 0.29
250–499 7 (70.0%) 6 (40.0%)
$500 2 (20.0%) 4 (26.7%)
aBlood was tested for CD4 cell count for 10 cases and 15 controls only.
doi:10.1371/journal.pone.0020111.t002
Table 3. Results of bivariate and multivariable analysis of risk factors for hospitalized influenza A and B, indicating the factors that
were included in the multivariate model (p,0.10), Bondo District, Kenya, 2007-9.
Bivariate Multivariable
Risk factor
Cases N=64
n( % )
Controls N=190
(%) n (%) ORMH (95% CI) P value Adjusted OR (95% CI)
Current Pulmonary TB 4 (6.3) 1 (0.5) 12.00 (1.34–107.37) 0.0045 NS
Chronic lung Disease 6 (9.4) 3 (1.6) 5.89 (1.47–23.65) 0.005 6.83 (1.37–33.98)
Chronic Heart Disease 3 ( 4.7) 1 (0.5) 9.00 (0.94–86.53) 0.021 NS
HIV positive
a 13 (24.5) 17 (12.5) 7.00 (1.69–28.93) 0.0041 3.56 (1.26–10.07)
HIV status unknown 11 (21.6) 54 (31.2) 0.56 (0.25–1.26) 0.15 0.82 (0.37–1.85)
Owns cattle 44 (68.8) 101 (53.2) 2.10 (1.09–4.04) 0.024 2.02 (1.01–4.07)
Median number cattle (range) 3 (0–40) 1(0–38) -- 0.013 NS
Median number of chickens (range) 9.5 (0–99) 7 (0–50) -- 0.022 1.04 (1.01–1.07)
aTotal number of cases and controls tested was 53 and 136 respectively. Reference group is HIV-negative.
doi:10.1371/journal.pone.0020111.t003
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associated pneumonia had a higher case-fatality ratio (8%) than
did HIV-negative children (2%) [12,13]. No data are available
before this study on the contribution of HIV infection to influenza
hospitalization in African adults [2]. In the U.S., one study showed
that HIV-infected women had the highest influenza-attributable
risk for severe cardiopulmonary events of any high risk group [14].
In an outbreak of influenza in a rehabilitation center in Italy, HIV-
infected persons had an increased risk of influenza-like illness (ILI),
as well as undefined complications [15]. In an outbreak in a
substance abuse rehabilitation center in New York, there was no
increased risk of ILI among HIV-infected residents, although 5%
of them were hospitalized versus none of the HIV-negative ILI
residents [16]. In our study, like previous studies, CD4 count was
not associated with risk of hospitalized pneumonia among HIV-
infected persons [15–17].
Whether the increase in influenza hospitalization among HIV-
infected persons is due to an increased susceptibility to influenza
virus infection, a greater chance of developing severe complica-
tions of influenza or a lower threshold of clinicians to hospitalize
HIV-infected persons is not clear. HIV-infected persons do appear
to have higher rates of severe influenza complications, hospital-
ization and death than HIV-negative people, based on findings
from developed countries [14,16–18]. This is also likely the case in
Africa, where co-morbidities among HIV-infected persons, such as
tuberculosis, are even more prevalent [5,6]. It is also possible that
HIV-infected persons with influenza are more likely to develop
secondary bacterial pneumonia leading to their hospitalization, as
suggested by an increase in suspected bacterial pneumonia among
HIV-infected children hospitalized with influenza in South Africa
[3,12]. Another potential explanation is that clinicians who know
that someone with respiratory illness is HIV-infected might be
more likely to hospitalize that person or that persons with HIV-
infection who develop influenza are more likely to seek care at
hospitals. We believe that the latter is likely not a large contributor
in rural western Kenya, where more than two-thirds of HIV-
infected persons did not know their HIV status [8]. Lastly, it is also
possible that HIV-infected persons are admitted for other
concomitant HIV-related diseases rather than for influenza. Fewer
than 30% of case-patients had an admitting diagnosis of
pneumonia; however, the influenza testing results were not
available to hospital clinicians, who make most diagnoses
empirically without radiologic or laboratory data, including blood
smears for malaria, which tends to be over-diagnosed in this
setting [19].
Characterizing an increased risk of influenza complications
among HIV-infected persons would be especially important in
sub-Saharan Africa, where 22 million people are estimated to have
HIV/AIDS [8,20]. Several interventions may decrease the
influenza burden in HIV-infected persons. Highly active antiret-
roviral therapy (HAART) has been shown to decrease the risk of
influenza complications [17,21]. Although most HIV-infected
Africans who need HAART are still not receiving it, the
percentage is increasing as efforts to expand HIV testing and
Table 4. Results of bivariate and multivariable analysis of risk factors for hospitalized influenza A, indicating the factors that were
included in the multivariate model (p,0.10), Bondo District, Kenya, 2007-9.
Bivariate Multivariable
Risk factor
Cases N =38
n( % )
Controls N =114 (%)
n (%) ORMH (95% CI) P value Adjusted OR (95% CI)
Current Pulmonary TB 2 (5.3%) 1 (0.9%) 6.00 (0.54–66.17) 0.096 NS
Chronic lung disease 1 (2.6%) 1 (0.9%) 3.00 (0.19–47.97) 0.44 NS
Chronic Heart Disease 2 (5.3%) 1 (0.9%) 6.00 (0.54–66.17) 0.096 NS
HIV positive
a 8 (21.1%) 10 (8.8%) 4.70 (1.08–20.50) 0.035 3.87 (1.13–13.23)
HIV status unknown 6 (15.8%) 32 (28.1%) 0.68 (0.23–2.02) 0.49 0.58 (0.20–1.63)
Median number cows (range) 4 (0–30) 1 (0–38) -- 0.055 NS
Median number of chickens 10 (0–99) 7 (0–50) -- 0.015 1.05 (1.01–1.08)
aTotal number of cases and controls tested was 32 and 82 respectively. Reference group is HIV-negative.
doi:10.1371/journal.pone.0020111.t004
Table 5. Results of bivariate and multivariable analysis of risk factors for hospitalized influenza B, indicating the factors that were
included in the multivariate model (p,0.10), Bondo District, Kenya, 2007-9.
Bivariate Multivariable
Risk factor Cases N =26 n (%)
Controls N =76
(%) n (%) ORMH (95% CI) P value Adjusted OR (95% CI)
Current Pulmonary TB 2 (7.7%) 0 -- 0.063 NS
Chronic lung Disease 5 (19.2%) 2 (2.6%) 7.33 (1.42–38.00) 0.0064 7.11 (1.38–36.75)
HIV positive
a 5 (23.8%) 7 (13.0%)z Undefined 0.16
HIV unknown 5 (23.8%) 22 (31.9%) 0.49 (0.12–1.90) 0.30 NS
Owns cows 19 (73.1%) 41 (53.9%) 3.10 (0.94–10.20) 0.073 NS
aTotal number of cases and controls tested was 21 and 53 respectively. Reference group is HIV-negative.
doi:10.1371/journal.pone.0020111.t005
Risk Factors for Severe Influenza, Kenya
PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e20111implement widespread HIV treatment increase in Africa [8].
Second, several studies suggest that influenza vaccine is effective in
HIV-infected persons who are not severely immunocompromised
[16,17,22,23]. The only randomized controlled trial designed to
address efficacy of influenza vaccine in HIV-infected persons
showed a 20% reduction in influenza-like illness and 100%
efficacy against lab-confirmed influenza [23]. Currently, influenza
vaccine is not available in the public sector in most of sub-Saharan
Africa [2,4].
We found persons with chronic lung disease were at increased
risk of influenza hospitalization, which is consistent with previous
studies done in the U.S. [24,25]. Pulmonary TB also had a
significant association with hospitalized influenza in bivariate, but
not multivariable, analysis. As with HIV, because we focused on
influenza among hospitalized patients, we were unable to
distinguish whether persons with TB and chronic lung disease
are more likely to become infected with seasonal influenza viruses,
or whether once infected they are more likely to develop severe
disease requiring hospitalization. In addition, healthy controls
might have had fewer contacts with the healthcare system in the
past year, therefore lacking the opportunity to be diagnosed with
pulmonary TB or chronic lung disease that cases had, leading to a
misclassification bias.
We found that influenza hospitalization was associated with
ownership of cattle and chickens. This association most likely
reflects confounding, as animal-to-human transmission of influen-
za viruses, although documented, is very rare, especially for
seasonal influenza viruses [26–29]. What the potential confound-
ers might be are not clear. People who own domestic animals may
have more contact with other people in crowded settings, such as
animal markets, increasing the opportunity for influenza trans-
mission. There might also be selection bias in that animal owners
who were eligible to be controls might have been less likely to be at
home or take the time to participate in the study. Additionally,
animal owners might represent a different category of persons,
with greater social mobility or access to healthcare, more likely to
go to hospitals when ill, making them more likely to be cases.
Several limitations might have affected our study. First, HIV
status at the time study enrollment was assumed to be the status at
the time of influenza infection. While this was likely the case, it is
possible that a few people had sero-converted in the interval
between influenza virus infection and study enrollment, although
this misclassification should have been non-differential between
cases and controls. In addition, two cases died between hospital
discharge and study enrollment and could not be HIV-tested by
the study team. Because they died, they had a higher probability of
being HIV-infected, which might have led to an underestimation
of the true risk of HIV. Second, inherent in the design of case-
control studies is the possibility of recall bias. Cases might have
remembered some exposures more than controls. Moreover, many
months often elapsed between illness and interviews, so that
exposures in the week prior to illness might not have been
remembered well. Nonetheless, many factors we evaluated are
unlikely to change over time, and both cases and controls were
asked to recall exposures during time periods similarly distant.
Third, not all hospitalized patients with respiratory illness met the
screening criteria, as we used an established severe acute
respiratory illness surveillance case definition, so that some
inpatients with influenza were not included [10]. In particular,
we did not include patients without documented fever or hypoxia.
Therefore, it is possible that our findings are not generalizable to
all influenza-associated hospitalizations.
This study underscores the role of underlying conditions,
particularly HIV infection, in hospitalized seasonal influenza
patients in Africa. Persons with such conditions should be
prioritized for influenza vaccination and other preventive
strategies. The effect of these conditions on the burden of severe
influenza disease during the recent 2009 H1N1 pandemic needs
further exploration.
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